|
|
|
시장보고서
Minimally Invasive and Non Invasive Surgery Market (2009 - 2014)
|
Abstract
Report Description
The healthcare industry has recently witnessed the adoption of many new
technologies that increase the efficiency of various medical treatments.
Minimally invasive surgery (MIS) is one of the most important developments
among all such cutting-edge medical technologies. This report uses the term
‘minimally invasive surgery' to include non-invasive surgeries as well.
The increasing demand of specialized treatment has propelled the market growth
for MIS; and many companies - especially the new entrants from developing
nations - are competing to benefit out of the rapid growth of this market.
With its progressive technological advancements such as capsule endoscopy and
drug eluting stent, the MIS market is set to evolve due to the increasing
demand for patient convenience, such as painless treatment and reduced
post-operative stay. The MIS market has a current potential of $16.4 billion
and is expected to grow at a CAGR of 8.3% between 2009 and 2014. The U.S.
holds the major share of the global MIS market; and the growth of the U.S.
market is driven by its growing ageing population and improvements in MIS
technologies.
Market estimates and forecasts
The report provides in-depth market estimates and forecast for global minimally invasive/non-invasive market as follows:
- MIS market - products : Surgical devices, monitoring and
visualization systems, endosurgical equipment, medical robotics, and
electrosurgical equipment
- MIS market - application: Gastrointestinal surgery, gynaecological
surgery, urological surgery, cosmetic surgery, obesity surgery, thoracic
surgery, cardiac surgery, vascular surgery, orthopaedic surgery, and other
surgery
- MIS market - technology: Transcatheter surgery, laparoscopy,
non-visual imaging, and medical robotics
- MIS market - end user: Hospital surgical departments, outpatient
surgery centres, group practices, individual surgeons, medical schools, and
other users
Each section will provide market data, market drivers, trends and
opportunities, top-selling products, key players, and competitive outlook.
This report will also provide more than 100 market tables for various
geographic regions covering the sub-segments and micro-markets. In addition,
the report also provides 50 company profiles for each of its sub-segments.
What makes our reports unique?
- We provide the longest market segmentation chain in this industry- not
many reports provide market breakdown upto level 5.
- Each report is about 250 pages with 100+ market data tables, 40
competitive company profiles, analysis of 300 patents and minimum 50 micro
markets, which are collectively exhaustive and mutually exclusive.
- No single report by any other publisher provides market data for all the
segments viz products, services, applications, ingredients, technology, and
stakeholders in a single report for all the four geographies - US, Europe,
APAC, ROW.
- We provide 10% customization - Research shows that more than 40% of the
times, clients do not get the specific intelligence they need in multi-client
market research reports. We offer 10% customization in our reports at no extra
cost. Get the exact market intelligence you require with real value for money.
- 15 pages of high level analysis including benchmarking strategies, best
practices and the market' s cash cows (BCG matrix). We conduct detailed market
positioning, product positioning and competitive positioning. Entry
strategies, gaps and opportunities are identified for all the stakeholders.
- Comprehensive market analysis for pharmaceutical and biotech companies,
medical device manufacturers, pharma-research labs, doctors, physicians and
hospitals, medical/pharma associations, retailers and super-retailers,
technology providers, and research and development (R&D) companies.
Key questions answered
- Which are the high-growth segments/cash cows and how is the market
segmented in terms of applications, products, services, ingredients,
technologies, and stakeholders?
- What are market estimates and forecasts; which markets are doing well and
which are not?
- Where are the gaps and opportunities; what is driving the market?
- Which are the key playing fields? Which are the winning edge imperatives?
- How is the competitive outlook; who are the main players in each of the
segments; what are the key selling products; what are their strategic
directives, operational strengths and product pipelines? Who is doing what?
Powerful Research and analysis
The analysts working with MarketsandMarkets come from renowned publishers and
market research firms, globally, adding their expertise and domain
understanding. We get the facts from over 22,000 news and information sources,
a huge database of key industry participants and draw on our relationships
with more than 900 market research companies across the world. We, at
MarketsandMarkets, are inspired to help our clients grow by providing
qualitative business insights with our huge market intelligence repository.
Table of Contents
1. INTRODUCTION
- 1.1. KEY TAKE AWAYS
- 1.2. MARKETS COVERED
- 1.3. STAKEHOLDERS
- 1.3.1. MINIMALLY/NON-INVASIVE SURGICAL EQUIPMENT MANUFACTURING COMPANIES
- 1.3.2. HOSPITAL SURGICAL DEPARTMENTS AND INDIVIDUAL SURGEONS
- 1.3.3. OUTPATIENT SURGERY CENTERS
- 1.3.4. BUSINESS RESEARCH AND CONSULTING SERVICE PROVIDERS
2. SUMMARY
3. MARKET OVERVIEW
- 3.1. EVOLUTION OF THE MINIMALLY INVASIVE SURGERY MARKET
- 3.1.1. MINIMALLY INVASIVE SURGERY VS CONVENTIONAL OPEN SURGERY
- 3.2. THE FUTURE OF MINIMALLY INVASIVE SURGERY
- 3.3. DEFINING THE MINIMALLY INVASIVE SURGERY MARKET
- 3.4. DEFINING THE MINIMALLY INVASIVE PRODUCT MARKET
- 3.5. DEFINING THE MINIMALLY INVASIVE APPLICATION MARKET
- 3.6. DEFINING THE MINIMALLY INVASIVE TECHNOLOGY MARKET
- 3.7. DEFINING THE MINIMALLY INVASIVE END-USER MARKET
- 3.8. MARKET DRIVERS FOR MINIMALLY INVASIVE SURGERY MARKET
- 3.8.1. INCREASE IN AGING POPULATION BOOSTS THE DEMAND FOR SURGERIES
- 3.8.2. INCREASE IN AWARENESS AND DEMAND FOR PATIENT-FRIENDLY OPERATING
METHODS
- 3.8.3. MINIMALLY INVASIVE SURGERY HELPS REDUCE HEALTHCARE COST
- 3.9. RESTRAINTS FOR THE MINIMALLY INVASIVE SURGERY MARKET
- 3.10.OPPORTUNITIES IN THE MINIMALLY INVASIVE SURGERY MARKET
- 3.10.1. HUGE MARKET SIZE ATTRACTING NEW ENTRANTS IN MINIMALLY INVASIVE
MARKET
- 3.10.2. PHYSICIANS ARE SETTING A STRONG FOUNDATION FOR THE FUTURE OF
MINIMALLY INVASIVE SURGERY MARKET
4. MINIMALLY INVASIVE PRODUCT MARKET
- 4.1. SURGICAL DEVICES
- 4.1.1. MARKET DRIVERS
- 4.1.1.1. INNOVATIVE MARKETING MODEL BOOSTING THE DEMAND FOR MIS
INSTRUMENTS
- 4.1.1.2. INCREASING NUMBER OF MIS PROCEDURES IS BOOSTING THE DEMAND
FOR MIS INSTRUMENTS
- 4.1.2. HAND INSTRUMENTS
- 4.1.3. FORCEPS/GRASPERS/DISSECTORS
- 4.1.4. SCISSORS
- 4.1.5. INSUFFLATORS
- 4.1.6. POWER SURGICAL INSTRUMENTS
- 4.1.7. OTHER SURGICAL DEVICES
- 4.2. MONITORING AND VISUALIZATION SYSTEMS
- 4.2.1. MARKET DRIVERS
- 4.2.2. CAMERAS AND VIDEO SUPPORT
- 4.2.3. OTHER MONITORING AND VISUALIZATION MARKET
- 4.3. ELECTROSURGICAL AND AUXILIARY EQUIPMENT
- 4.3.1. LASERS
- 4.3.2. OTHER MARKET
- 4.4. ENDOSURGICAL EQUIPMENT
- 4.4.1. MARKET DRIVERS
- 4.4.2. ENDOSCOPES AND OTHER ENDOSURGICAL EQUIPMENT
- 4.5. MEDICAL ROBOTICS
- 4.5.1. MARKET DRIVERS
- 4.5.1.1. IMPROVED SURGICAL RESULTS ATTRACTING MORE PATIENTS
- 4.5.1.2. MEDICAL ROBOTICS INCREASE HOSPITAL REVENUE
- 4.5.2. SURGICAL NAVIGATION SYSTEMS
- 4.5.3. SURGICAL ROBOTS
- 4.5.4. DIGITAL OPERATING ROOMS
- 4.5.5. OTHERS
5. MINIMALLY INVASIVE SURGERY MARKET BY APPLICATION
- 5.1. COSMETIC SURGERY
- 5.1.1. DRIVERS
- 5.1.2. PLASTIC SURGERY
- 5.1.3. BREAST SURGERY
- 5.1.4. OBESITY SURGERY
- 5.1.4.1. DRIVERS
- 5.1.4.1.1. INCREASING INCIDENCE OF OBESITY IS DRIVING THE BARIATRIC
SURGERY MARKET
- 5.1.4.1.2. INCREASE IN AWARENESS OF OBESITY AS A DANGEROUS DISEASE
- 5.1.5. HAIR REMOVAL
- 5.1.5.1. DRIVERS AND RESTRAINTS
- 5.2. GASTROINTESTINAL SURGERY
- 5.3. GYNECOLOGICAL SURGERY
- 5.4. UROLOGICAL SURGERY
- 5.5. THORACIC SURGERY
- 5.6. CARDIAC SURGERY
- 5.6.1. DRIVERS
- 5.6.1.1. TECHNOLOGY DEVELOPMENTS ARE BOOSTING THE CARDIAC SURGERY
MARKET
- 5.6.1.2. NEW AND IMPROVED SURGICAL PROCEDURES DRIVING THE MARKET
GROWTH FOR CARDIAC SURGERY
- 5.6.2. ROBOT-ASSISTED CARDIAC SURGERY
- 5.7. VASCULAR SURGERY
- 5.8. ORTHOPEDIC SURGERY
- 5.8.1. JOINT REPLACEMENT
- 5.8.2. SPINAL SURGERY
- 5.8.3. OTHER SURGERIES
6. MINIMALLY INVASIVE SURGERY MARKET-BY TECHNOLOGY
- 6.1. NON-VISUAL IMAGING
- 6.1.1. OPTICAL IMAGING
- 6.1.2. NON-OPTICAL IMAGING
- 6.1.3. HYBRID IMAGING
- 6.2. MEDICAL ROBOTICS
- 6.2.1. MARKET DRIVERS
- 6.2.1.1. Improved Surgical Results Attracting Patients
- 6.2.1.2. Cost effectiveness Attracting Medical Facilities
- 6.3. TRANSCATHETER SURGERY
- 6.3.1. PERCUTANEOUS ABLATION
- 6.3.2. RADIOFREQUENCY ABLATION
- 6.3.2.1. Market Drivers
- 6.3.2.1.1. Increasing Consumer Base Driving the Market Growth for RFA
- 6.3.2.1.2. RFA Gives More Effective Results for Treatment of Liver
Tumor
- 6.3.2.1.3. Most Promising Nonsurgical Ablation for Breast Cancer
Treatment
- 6.3.2.2. Restraints
- 6.3.2.3. Developments
- 6.3.3. MICROWAVE ABLATION
- 6.3.3.1. Market Drivers
- 6.3.3.1.1. Microwave Ablation Takes Lesser Time for Operating Tumors
- 6.3.3.1.2. Microwave Ablation Involves Faster Generation of Heat
- 6.4. LAPAROSCOPIC SURGERY
7. MINIMALLY INVASIVE SURGERY MARKET BY END-USERS
- 7.1. HOSPITAL SURGICAL DEPARTMENTS
- 7.2. OUTPATIENTS SURGERY CENTER
- 7.3. GROUP PRACTICES
- 7.4. INDIVIDUAL SURGEONS
- 7.5. MEDICAL SCHOOLS
- 7.6. OTHER USERS
8. MINIMALLY INVASIVE SURGERY PATENT ANALYSIS
9. MINIMALLY INVASIVE SURGERY MARKET COMPANY PROFILES
- 9.1. ABBOTT LABORATORIES
- 9.1.1. OVERVIEW
- 9.1.2. STRATEGIES AND DEVELOPMENTS
- 9.2. AESCULAP (A SUBSIDIARY OF B. BRAUN)
- 9.2.1. OVERVIEW
- 9.2.2. STRATEGIES AND DEVELOPMENTS
- 9.3. ARTHROCARE CORP.
- 9.3.1. OVERVIEW
- 9.3.2. STRATEGY AND DEVELOPMENTS
- 9.4. BIOMET, INC.
- 9.4.1. OVERVIEW
- 9.4.2. DEVELOPMENTS
- 9.5. DEPUY SPINE
- 9.5.1. OVERVIEW
- 9.5.2. STRATEGIES AND DEVELOPMENTS
- 9.6. DISC-O-TECH MEDICAL TECHNOLOGIES LTD
- 9.7. ALPHATEC SPINE
- 9.7.1. OVERVIEW
- 9.7.2. STRATEGIES AND DEVELOPMENTS
- 9.8. GIVEN IMAGING
- 9.8.1. OVERVIEW
- 9.8.2. STRATEGIES AND DEVELOPMENTS
- 9.9. HANSEN MEDICAL
- 9.9.1. OVERVIEW
- 9.9.2. STRATEGIES AND DEVELOPMENTS
- 9.10.INTEGRA LIFESCIENCES
- 9.10.1.OVERVIEW
- 9.10.2.STRATEGIES AND DEVELOPMENTS
- 9.11.MENTICE MEDICAL SIMULATION
- 9.11.1.OVERVIEW
- 9.11.2.STRATEGY
- 9.12.NUVASIVE INC.
- 9.12.1.OVERVIEW
- 9.12.2.DEVELOPMENTS
- 9.13.OLYMPUS CORPORATION
- 9.13.1.OVERVIEW
- 9.13.2.STRATEGIES AND DEVELOPMENTS
- 9.14.SMITH & NEPHEW
- 9.14.1.OVERVIEW
- 9.14.2.STRATEGIES AND DEVELOPMENTS
- 9.15.STRYKER CORPORATION
- 9.15.1.OVERVIEW
- 9.15.2.STRATEGIES AND DEVELOPMENTS
- 9.16.SYNTHES, INC.
- 9.16.1.OVERVIEW
- 9.16.2.STRATEGY
- 9.17.TELEFLEX
- 9.17.1.OVERVIEW
- 9.17.2.STRATEGIES AND DEVELOPMENTS
- 9.18.COVIDIEN LTD
- 9.18.1.OVERVIEW
- 9.18.2.STRATEGIES AND DEVELOPMENTS
- 9.19.UNITED STATES SURGICAL CORP. (A SUBSIDIARY OF COVIDIAN)
- 9.20.ZIMMER HOLDINGS INC.
- 9.20.1.OVERVIEW
- 9.20.2. STRATEGIES
- 9.21.MEDTRONIC SOFAMOR DANEK
- 9.21.1.OVERVIEW
- 9.21.2.STRATEGIES
- 9.22.PENTAX MEDICAL COMPANY
- 9.22.1.OVERVIEW
- 9.22.2.STRATEGIES AND DEVELOPMENTS
- 9.23.SURGICAL INNOVATIONS GROUP PLC.
- 9.23.1.OVERVIEW
- 9.23.2.DEVELOPMENTS
- 9.24.K2M INC
- 9.24.1.OVERVIEW
- 9.24.2.DEVELOPMENTS
- 9.25.BOSTON SCIENTIFIC CORPORATION
- 9.25.1.OVERVIEW
- 9.25.2.STRATEGIES AND DEVELOPMENTS
- 9.25.3. DEVELOPMENTS
- 9.26.CHARLES RUSSELL BARD INC.
- 9.26.1.OVERVIEW
- 9.26.2.STRATEGIES AND DEVELOPMENTS
- 9.27.FUJIFILM CORPORATION
- 9.27.1.OVERVIEW
- 9.27.2.STRATEGIES AND DEVELOPMENTS
- 9.28.KARL STORZ ENDOSKOPE BERLIN GMBH & CO
- 9.28.1.OVERVIEW
- 9.28.2.STRATEGY
- 9.29.GYRUS ACMI CORP.
- 9.30.COOPER SURGICAL INC.
- 9.30.1.OVERVIEW
- 9.30.2.STRATEGIES AND DEVELOPMENTS
- 9.31.CLARUS MEDICAL LLC
- 9.31.1.OVERVIEW
- 9.31.2.STRATEGIES
- 9.32.ETHICON ENDO-SURGERY, INC.
- 9.32.1.OVERVIEW
- 9.32.2.STRATEGY
- 9.33.VALLEYLAB
- 9.33.1.OVERVIEW
- 9.33.2.STRATEGIES
- 9.34.JOHNSON & JOHNSON INC.
- 9.34.1.OVERVIEW
- 9.34.2.DEVELOPMENTS
- 9.35.CONMED CORPORATION
- 9.35.1.OVERVIEW
- 9.35.2.DEVELOPMENTS
- 9.36.INTUITIVE SURGICAL INC
APPENDIX
U.S. PATENTS
|
 |
